作者: Christine L Lau , Melissa Logan , Irving L Kron
DOI: 10.2217/AHE.09.77
关键词:
摘要: The first long-term, successful, human-isolated lung transplant was performed in 1983 by the Toronto Lung Transplant Group. Two and a half decades have passed since this landmark procedure almost 19,000 transplants been performed. At present, transplantation is preferred treatment option for variety of end-stage pulmonary diseases. Remarkable progress has occurred through refinement technique improved understanding immunology microbiology. Elderly recipients usually undergo chronic obstructive disease or idiopathic fibrosis face unique challenges. It increasingly evident that ‘biologic age’ more important than actual recipient age. Postoperative immunosuppression regimens education require greater individualization elderly adults owing to increased risk infection involved with complications. A multidiscipliniary approach transplantation, especially ...